Neurology company Aquestive raises $67.5M IPO

Aquestive Therapeutics Inc. (NASDAQ:AQST) added $1.05 to $16.05 on July 25 after raising $67.5 million through the sale of 4.5 million shares at $15 in an upsized IPO. Underwriters were BMO Capital Markets, RBC Capital Markets, Wedbush PacGrow and JMP Securities.

Aquestive priced its offering in the middle of its proposed range of $14-$16. This month, the company had hoped to sell 4 million shares...